Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-04-13 2020-04-13
Drug Identification Number 00607142 00607142
Brand name ERYC DELAYED-RELEASE CAPSULES ERYC DELAYED-RELEASE CAPSULES
Common or Proper name Eryc Eryc
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ERYTHROMYCIN ERYTHROMYCIN
Strength(s) 250MG 250MG
Dosage form(s) CAPSULE (ENTERIC-COATED) CAPSULE (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 1 x 100s 1 x 100s
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-04-01 2020-04-01
Actual discontinuation date 2020-04-07 2020-04-07
Remaining supply date 2020-04-01 2020-04-01
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Eryc 333mg 1x100s presentation remains available Eryc 333mg 1x100s presentation remains available
Health Canada comments